About Us
We’re made for this opportunity
The Cannex Scientific team has a solid foundation of scientific expertise and business savvy. Together we’re building a culture of innovation guided by a shared set of values that shape every facet of our work.
Growth through experimentation and innovation
Respect for colleagues, partners, and patients
Individual Responsibility of each team member
Passion to solve complex unmet health needs
Leadership
Rebecca Bagley
Chief Executive Officer
Innovative leader that has diverse business background and the ability to translate science to the commercial market.
Dr. Börk Balkan
Chief Scientific Officer
Experienced scientist with leadership roles in pharma and biotech. Responsible for drug discovery programs from early proof-of-concept to clinical development.
Founders
Rebecca Myers
Co-founder, Executive Board Chair
Healthcare industry veteran with deep leadership experience. Founder and CEO of FARMACEUTICALRX.
Dr. Dietrich Stephan
Co-founder, Director
Father of precision medicine. Led discovery research at TGen. Co-founder of 14 biotech companies, including NASDAQ listed.
Research & Clinical
CORE TEAM
Luke P. Lee, PhD
Harvard Medical School, Brigham and Women’s Hospital
Expertise in microfluidics, brain organoids, biosensors, molecular diagnostics, and quantum biology.
Aaron Goldman, PhD
Harvard Medical School, Brigham and Women’s Hospital
Expertise in cannabinoid in-vitro research, molecular diagnostics, computational models, and cellular heterogeneity.
Ilana Braun, MD
Harvard Medical School, Dana-Farber Cancer Institute
Expertise in clinical psychiatry, neurophysiology, human and animal behavior, and in-vivo models.
Key Collaborators & Advisors
Scientific Advisory Board
We are finalizing the administrative process for several additional advisory board members, please check back soon for updates.
Peter Barton Hutt
Senior Counsel Covington & Burling LLP
Legend of food and drug law. Former Chief Counsel of the Food and Drug Administration, led modernization of the agency.
